Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST11 VTP in Localized Prostate Cancer
NCT00946881Phase 2Completed
- Sponsor
- Steba Biotech
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of padeliporfin in prostate cancer (PCa), sponsored by Steba Biotech. Primary endpoint: Prostate Biopsy Outcome at Month 6. Started Jul 2009; status: completed.
02
Drugs
padeliporfin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00946881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946881.